Big News for Hospitalists: Elimination of the X-Waiver

On January 12, 2023, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced the immediate elimination of the X-Waiver for prescribing buprenorphine, as required by the omnibus bill passed in December 2022. The Society of Hospital Medicine (SHM) celebrates this change as a major victory for our collective advocacy efforts and for improving the care of patients with opioid use disorder (OUD).